MEDIPOST (Korea) Analysis

MEDIPOST Stock Analysis Notes

The company has Price/Earnings (P/E) ratio of 9635.53. MEDIPOST had not issued any dividends in recent years. The entity had 2:1 split on the 29th of March 2019. MEDIPOST Co., Ltd. provides stem cell therapeutic solutions to meet the unmet medical needs in South Korea and internationally. MEDIPOST Co., Ltd. was founded in 2000 and is headquartered in Seongnam, South Korea. MEDIPOST is traded on Korean Securities Dealers Automated Quotations in South Korea. For more info on MEDIPOST Co please contact Yun Yang at (82) 2 3465 6688 or go to www.medi-post.co.kr.

MEDIPOST Investment Alerts

MEDIPOST Market Capitalization

The company currently falls under 'Mega-Cap' category with a current market capitalization of 241.31 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MEDIPOST's market, we take the total number of its shares issued and multiply it by MEDIPOST's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

MEDIPOST Profitablity

The company has Profit Margin (PM) of (0.1) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07.

Technical Drivers

As of the 21st of December, MEDIPOST secures the mean deviation of 4.45, and Risk Adjusted Performance of 0.178. MEDIPOST Co technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.

MEDIPOST Price Movement Analysis

MEDIPOST Outstanding Bonds

MEDIPOST Predictive Daily Indicators

MEDIPOST Forecast Models

MEDIPOST's time-series forecasting models are one of many MEDIPOST's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MEDIPOST's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how MEDIPOST prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MEDIPOST shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as MEDIPOST. By using and applying MEDIPOST Stock analysis, traders can create a robust methodology for identifying MEDIPOST entry and exit points for their positions.

When running MEDIPOST's price analysis, check to measure MEDIPOST's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIPOST is operating at the current time. Most of MEDIPOST's value examination focuses on studying past and present price action to predict the probability of MEDIPOST's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIPOST's price. Additionally, you may evaluate how the addition of MEDIPOST to your portfolios can decrease your overall portfolio volatility.